In-house Pipeline
: IIT
: SIT
Pipeline
Indication
| Pipeline | Indication | in silico | in vitro | in vivo | IND | clinical trials |
|---|---|---|---|---|---|---|
| OC101 | Liver Cirrhosis |
OC101
Liver Cirrhosis
|
||||
| OC101+OC111 | NASH |
OC101+OC111
NASH
|
||||
| OC201+OC202e | Inhibition of Cancer Metastasis |
OC201+OC202e
Inhibition of Cancer Metastasis
|
||||
| OC211 | Pan-KRAS Inhibitor |
OC211
Pan-KRAS Inhibitor
|
||||
| OC514 | ALS, DMD |
OC514
ALS, DMD
|
||||
| OC514 (Korea) | Aging Sarcopenia |
OC514 (Korea)
Aging Sarcopenia
|
||||
| OC514 (Global) | Cancer Sarcopenia |
OC514 (Global)
Cancer Sarcopenia
|
||||
| OC601 | COVID-19 |
OC601
COVID-19
|
||||
| OC701 | Atopic Dermatitis |
OC701
Atopic Dermatitis
|
||||
